vaccines

A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight
A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight
Fierce Biotech
type 1 diabetes
Provention Bio
vaccines
PRV-101
Flag link:
Sanofi and Merck Snag FDA Approval for a Six-Disease Combination Vaccine
Sanofi and Merck Snag FDA Approval for a Six-Disease Combination Vaccine
BioSpace
vaccines
FDA
Vaxelis
diphtheria
tetanus
pertussis
polio
hepatitis B
haemophilus influenza type b
Sanofi
Merck
Flag link:
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
CP Wire
Pfizer
vaccines
pneumococcal disease
pneumonia
20VPnC
Flag link:
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
Pfizer
20VPnC
vaccines
pneumococcal disease
pneumonia
Flag link:
GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'
GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019'
Fierce Pharma
GSK
shingles
vaccines
Shingrix
drug shortages
Flag link:
Why Novavax Is Up 60% in 2018
Why Novavax Is Up 60% in 2018
Motley Fool
Novavax
NanoFlu
ResVax
vaccines
Flag link:
GlaxoSmithKline weighs plan to develop vaccine against fast-spreading gonorrhea: report
GlaxoSmithKline weighs plan to develop vaccine against fast-spreading gonorrhea: report
Fierce Pharma
GSK
Bexsero
vaccines
STD
gonorrhea
Flag link:
UT Researchers Discover Alzheimer's Vaccine, Hope To Test In Humans Soon
UT Researchers Discover Alzheimer's Vaccine, Hope To Test In Humans Soon
Forbes
Alzheimer's disease
R&D
vaccines
University of Texas
Flag link:
Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year
Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year
Fierce Pharma
Merck
vaccines
Congo
ebola virus
Flag link:
Boehringer backs $33M cancer vaccine play at Switzerland's AMAL Therapeutics
Boehringer backs $33M cancer vaccine play at Switzerland's AMAL Therapeutics
Endpoints
vaccines
cancer vaccines
Boehringer Ingelheim
Amal Therapeutics
Switzerland
Flag link:
Merck cuts back on vaccine commitment to West Africa as shipments to China ramp up
Merck cuts back on vaccine commitment to West Africa as shipments to China ramp up
Stat
Merck
vaccines
West Africa
China
rotavirus
Flag link:
Long-lasting HIV injection is a step closer after second GSK study
Long-lasting HIV injection is a step closer after second GSK study
Reuters
vaccines
GSK
HIV
cabotegravir
rilpivirine
Flag link:
FDA says it will consider approval of first dengue vaccine, despite controversy
FDA says it will consider approval of first dengue vaccine, despite controversy
Stat
FDA
Sanofi Pasteur
vaccines
Dengvaxia
dengue
Flag link:
'Unprecedented' demand for Merck's Gardasil drives monster Q3
'Unprecedented' demand for Merck's Gardasil drives monster Q3
Fierce Pharma
Merck
earnings
Gardasil
vaccines
HPV
Flag link:
Inovio touts intradermal delivery of HIV vaccine
Inovio touts intradermal delivery of HIV vaccine
Drug Delivery Business News
Invovio
HIV
vaccines
Pennvax-GP
Flag link:
J&J steps up vaccines R&D—and preps for launches—with €72M plant
J&J steps up vaccines R&D—and preps for launches—with €72M plant
Fierce Pharma
JNJ
vaccines
drug manufacturing
Flag link:
J&J touts latest immune response data for 'mosaic' HIV vaccine program
J&J touts latest immune response data for 'mosaic' HIV vaccine program
Fierce Pharma
JNJ
vaccines
HUV
Africa
Flag link:
Gilead, Aelix ally to trial HIV-suppressing combination
Gilead, Aelix ally to trial HIV-suppressing combination
Fierce Biotech
Gilead Sciences
Aelix Therapeutics
vaccines
antiretrovirals
HIV
Flag link:
Percentage of young U.S. children who don’t receive any vaccines has quadrupled since 2001
Percentage of young U.S. children who don’t receive any vaccines has quadrupled since 2001
Washington Post, DC
vaccines
Flag link:
Gardasil HPV Vaccine Approved for Use in Adults Up to Age 45, But Will This Age Group Get the Shot?
Gardasil HPV Vaccine Approved for Use in Adults Up to Age 45, But Will This Age Group Get the Shot?
Xtalks
Merck
vaccines
HPV
Gardasil 9
Flag link:

Pages